Merck's Frazier discusses deal appetite

Merck & Co. Inc. (NYSE:MRK) President and CEO Kenneth Frazier said the pharma is actively searching for licensing or bolt-on deals, and would consider a

Read the full 256 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE